Navigation Links
DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease
Date:2/12/2009

uce the need for systemic immunosuppressive drugs such as prednisone, which is currently used off label to prevent and control GI GVHD.

About Sigma-Tau Pharmaceuticals, Inc.

Sigma-Tau Pharmaceuticals, Inc. is a U.S.-based, wholly owned subsidiary of the Sigma-Tau Group, and is dedicated solely to the global development and commercialization of medicines for patients with rare diseases. Sigma-Tau Pharmaceuticals, Inc. is based in Gaithersburg, Maryland.

Since 1989, the company's products have been focused on rare diseases, kidney disease, and cancer. With more than 6,000 identified rare diseases that affect approximately 25 million patients in the Unites States, Sigma-Tau places its considerable scientific resources behind the development and commercialization of compounds that benefit the few. The company has a substantial development program focused on transplant, cancer, inherited genetic disorders, malaria, and other areas of unmet medical need. For more information about the company, please visit www.sigmatau.com.

About DOR BioPharma, Inc.

DOR BioPharma, Inc. (DOR) is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. DOR's lead product, orBec(R) (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of GI GVHD, a common and potentially life-threatening complication of HCT. DOR expects to begin a confirmatory Phase 3 clinical trial of orBec(R) for the treatment of acute GI GVHD and a Phase 1/2 clinical trial of Oral BDP in radiation enteritis in 1H 2009. orBec(R) is also currently the subject of an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial in the prevention of acute GVHD. Or
'/>"/>

SOURCE DOR BioPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. PDL BioPharma to Actively Seek Sale of Entire Company or Its Key Assets
2. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
3. Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting
4. Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG
5. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
6. Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association
7. XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007
8. ARCA Discovery Changes Name to ARCA biopharma to Reflect Focus on Drug Commercialization
9. CeNeRx BioPharma Appoints Mahnaz Asgharnejad as Vice President of Clinical Development
10. Immunosyn Announces Proposed Agreements for Distribution of the Biopharmaceutical SF-1019 in Utah
11. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 2014 A new, online conference is coming ... summit is no-cost and open to everyone. Over 20 ... tips and advice on how to stop emotional eating, start ... Mindful eating is not a diet. The concept is ... of an "eat this, don't eat that" approach. , You ...
(Date:8/22/2014)... 22, 2014 For patients who need surgery for ... procedure is the least often used, reports a study ... , official journal of the Congress of Neurological ... Williams & Wilkins , a part of Wolters ... good pain relief at much lower cost than other ...
(Date:8/22/2014)... New York, NY (PRWEB) August 22, 2014 ... Theresa Caputo tickets in Kalamazoo, New Orleans, Albuquerque ... family after death, the “Long Island Medium,” Theresa Caputo, allows ... on Long Island. She is part of a close knit ... child. After speaking with a spiritual healer, realized she had ...
(Date:8/22/2014)... FL (PRWEB) August 22, 2014 ... continues expansion of products in providing new recipe cards, ... casual wear. , Hailing from Clearwater, Florida, Pirate ... appreciate having 1 card with two to three recipes ... the recipes on the website. The ...
(Date:8/22/2014)... According to the new research report "Isocyanate Market ... Forecast to 2019" defines and segments the isocyanate ... market value. The isocyanate material market value will ... significant CAGR from 2014 to 2019. , Browse ... through 286 pages and in-depth TOC on "Isocyanate ...
Breaking Medicine News(10 mins):Health News:20 Top Experts Discuss How to Unravel the Food-Mood Connection 2Health News:More common procedures for painful facial tics carry high costs, reports study in Neurosurgery 2Health News:Theresa Caputo Tickets in Kalamazoo at Wings Stadium, Saenger Theatre in New Orleans, Kiva Auditorium in Albuquerque and Rapid City at Don Barnett Arena Now Available 2Health News:Pirate Jonny's Caribbean BBQ Rubs, Seasonings & Sauces Get New Look by Hoisting New Recipe Card Creations and New Clothing Apparel for its Logos 2Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 2Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 3Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 4
... and Washington University School of Medicine in St. Louis have ... 16 to// use of all-terrain vehicles (ATVs). This call was ... ,Children have no experience or training in driving motorized vehicles, ... see what's coming up ahead of them very well,' says ...
... with Florida-based Roskamp Institute to conduct a study on ... in Alzheimer's disease. // ,The Dublin Ageing ... Psychiatry from St James’ Hospital, Beaumont Hospital, James Connolly ... Adelaide and Meath Hospital and St Patrick’s Hospital will ...
... herbs, has now uncorked a new product: herbal wine. // ... a resident of tourist town Pokhara in western Nepal, whose ... ,For many families, alcohol is an integral part of life, ... liquors thrive in Nepal's markets along with foreign beers, whiskeys ...
... tailoring the intensity of radiation to individual patients and ... for those// suffering medulloblastoma. ,A team ... has announced that improved treatment measures for childhood brain ... of children with this disease. , ,The ...
... strong bones, strong and healthy teeth, and healthy muscles and ... vital to take plenty of calcium, especially in the adolescent ... osteoporosis. ,The growth of bone mass takes place ... by calcium in milk, cheese, yogurt, other dairy products, leafy ...
... drugs are released within a cancer cells.// ,A ... first time ever details of how drugs are released within ... the ability to deliver drugs to a specific target without ... indiscriminate delivery of drugs into every cell of the body ...
Cached Medicine News:Health News:Call To Ban Use Of ATVs By Children 2Health News:Nepal Uncorks 'Herbal Wine' 2Health News:Survival rates improve with better treatment options for medulloblastoma 2Health News:Survival rates improve with better treatment options for medulloblastoma 3Health News:Study Findings Could Help In Developing A Better Drug Delivery System 2Health News:Study Findings Could Help In Developing A Better Drug Delivery System 3Health News:Study Findings Could Help In Developing A Better Drug Delivery System 4
(Date:8/22/2014)... MC Medical, a subsidiary of Mitsubishi Corporation (MCM), and Minimally ... medical device company, have formally agreed to an exclusive ... in Japan . It is anticipated that ... in the latter half of 2015. ... in endoscopic surgery market in Japan . ...
(Date:8/22/2014)... ITHACA, N.Y. , Aug. 22, 2014 /PRNewswire/ ... computed tomography (CT) imaging facility, is using the ... 4D and even 5D imaging to researchers and ... just launched, asks "What would YOU do if ... the possibility to researchers and explorers everywhere, from ...
(Date:8/22/2014)... FREMONT, Calif. , Aug. 22, 2014  WaferGen ... an underwritten public offering of units of common stock ... for gross proceeds of $20 million, prior to deducting ... the Company.  The shares and warrants are immediately separable ... stock are expected to begin trading on The NASDAQ ...
Breaking Medicine Technology:MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4
... , BOSTON, Nov. 20 The United States ... an earlier District Court ruling yesterday, approving a settlement ... against AstraZeneca Pharmaceuticals ( AZN). , (Logo: http://www.newscom.com/cgi-bin/prnh/20080317/AQM144LOGO ... consumers who purchased the pharmaceutical giant,s prostate cancer drug ...
... , LOUISVILLE, Ky., Nov. 20 ... a new initiative in the war on methamphetamine. The ... program that enforces purchase limitations on over-the-counter (OTC) medicines containing ... technology for NPLEx is based on a system that was ...
Cached Medicine Technology:U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 2National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 3
Digital Ultrasonic Diagnostic Imaging System...
Quantitative Plasma-based Factor XIII Incorporation Assay Kit...
Pefakit PiCT LMWH Controls...
Calcium Chloride 0.020M - 4 ml...
Medicine Products: